Dual Antagonists of Integrins

E-ISSN： 1875-533x|12|12|1449-1466

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.12, Iss.12, 2005-06, pp. : 1449-1466

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Antagonists and the Conformational Regulation of the &bgr;2 Integrins

Current Topics in Medicinal Chemistry, Vol. 4, Iss. 14, 2004-10 ,pp. : 1485-1495

Bentham Science Publishers

Access to resources Recommend Favorite

Dual Mode of Action of Dihydropyridine Calcium Antagonists: A Role for Nitric Oxide

By Dhein S.

Drugs, Vol. 58, Iss. 3, 1999-09 ,pp. : 397-404

Adis International

Access to resources Recommend Favorite

Pfizer's dual-acting β₂ agonists/muscarinic M₃ antagonists

By Norman Peter

Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 9, 2008-09 ,pp. : 1091-1096

Informa Healthcare

Access to resources Recommend Favorite

Development and Potential Utility of Dual and Triple NK Receptor Antagonists

Current Topics in Medicinal Chemistry, Vol. 3, Iss. 12, 2003-08 ,pp. : 1410-1422

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery of Dual Orexin Receptor Antagonists (DORAs) for the Treatment of Insomnia

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 6, 2011-03 ,pp. : 696-725

Bentham Science Publishers

Access to resources Recommend Favorite